Kymera Therapeutics Inc. (KYMR) Social Stream
KYMERA THERAPEUTICS INC (KYMR) Price Targets From Analysts
Use the tables below to see what analysts covering KYMERA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-03 | 10 | $91 | $67 | $78.875 | $26.82 | 194.09% |
| 2022-02-24 | 11 | $91 | $62 | $77 | $26.82 | 187.1% |
| 2022-02-28 | 11 | $91 | $62 | $74.222 | $26.82 | 176.74% |
| 2022-03-02 | 11 | $91 | $62 | $74 | $26.82 | 175.91% |
| 2022-04-10 | 12 | $91 | $44 | $71 | $26.82 | 164.73% |
| 2022-05-03 | 11 | $91 | $44 | $71 | $26.82 | 164.73% |
| 2022-05-04 | 11 | $91 | $35 | $65.2 | $26.82 | 143.1% |
| 2022-05-09 | 11 | $91 | $35 | $64.2 | $26.82 | 139.37% |
| 2022-05-22 | 10 | $91 | $35 | $62.444 | $26.82 | 132.83% |
| 2022-06-01 | 10 | $85 | $35 | $57.111 | $26.82 | 112.94% |
| 2022-06-15 | 10 | $85 | $35 | $54.111 | $26.82 | 101.76% |
| 2022-06-21 | 10 | $93 | $35 | $55.555 | $26.82 | 107.14% |
| 2022-07-20 | 10 | $93 | $26 | $52.6 | $26.82 | 96.12% |
| 2022-08-03 | 11 | $93 | $26 | $51.454 | $26.82 | 91.85% |
| 2022-08-12 | 12 | $93 | $26 | $51.454 | $26.82 | 91.85% |
| 2022-08-13 | 13 | $93 | $26 | $51.454 | $26.82 | 91.85% |
| 2022-08-22 | 13 | $93 | $26 | $50.5 | $26.82 | 88.29% |
| 2022-10-13 | 12 | $93 | $26 | $50.666 | $26.82 | 88.91% |
| 2022-11-04 | 13 | $93 | $26 | $50.666 | $26.82 | 88.91% |
| 2022-11-07 | 14 | $93 | $26 | $49.166 | $26.82 | 83.32% |
| 2022-12-11 | 14 | $93 | $26 | $49.25 | $26.82 | 83.63% |
| 2022-12-15 | 14 | $93 | $31 | $51.5 | $26.82 | 92.02% |
| 2022-12-19 | 14 | $93 | $31 | $52.75 | $26.82 | 96.68% |
| 2023-01-02 | 14 | $93 | $31 | $52.666 | $26.82 | 96.37% |
| 2023-02-24 | 14 | $93 | $31 | $53.166 | $26.82 | 98.23% |
| 2023-03-03 | 14 | $93 | $31 | $52.916 | $26.82 | 97.3% |
| 2023-05-04 | 14 | $93 | $31 | $52.916 | $26.82 | 97.3% |
| 2023-05-08 | 14 | $93 | $31 | $51.384 | $26.82 | 91.59% |
| 2023-06-22 | 14 | $93 | $31 | $51.23 | $26.82 | 91.01% |
| 2023-06-30 | 15 | $93 | $31 | $51.142 | $26.82 | 90.69% |
| 2023-08-04 | 14 | $93 | $31 | $52.153 | $26.82 | 94.46% |
| 2023-08-07 | 13 | $93 | $31 | $52.461 | $26.82 | 95.6% |
| 2023-08-29 | 13 | $93 | $31 | $52.23 | $26.82 | 94.74% |
| 2023-11-02 | 13 | $93 | $25 | $47.077 | $26.82 | 75.53% |
| 2023-11-06 | 13 | $93 | $16 | $40.461 | $26.82 | 50.86% |
| 2023-11-10 | 13 | $93 | $16 | $38.846 | $26.82 | 44.84% |
| 2023-12-19 | 14 | $93 | $16 | $37.153 | $26.82 | 38.53% |
The Trend in the Analyst Price Target
KYMR's average price target has moved down $15.45 over the prior 17 months.
Over the past 50 weeks, KYMR's average upside potential has been 140.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-24 | 14 | 93 | 31 | 52.916 | 31.46 | 68.2% |
| 2023-02-24 | 14 | 93 | 31 | 53.000 | 31.46 | 68.47% |
| 2023-06-14 | 14 | 93 | 31 | 51.230 | 25.80 | 98.57% |
| 2023-06-30 | 15 | 93 | 31 | 51.142 | 22.99 | 122.45% |
| 2023-12-19 | 14 | 93 | 16 | 37.153 | 24.96 | 48.85% |
KYMR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.71 | 9 | 0 | 5 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
KYMR's average broker recommendation rating worsened by 0.16 over the prior 17 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how KYMERA THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -4039.58% of that group.
- In the context of all US stocks, KYMERA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 3831.47% of them.
- KYMR has a greater number of analysts covering the stock than 4122.49% of stocks in the mid market cap category.
- KYMERA THERAPEUTICS INC's average analyst price target is higher than 3400.63% of Pharmaceutical Products stocks.
Stocks similar to KYMERA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BCAB, TIL, and RXRX.
View All Top Stocks by Price Target
Is KYMR a Buy, Hold or Sell? See the POWR Ratings now!